Targeting M. Leprae survival strategies in the PNS
针对 PNS 中的麻风分枝杆菌生存策略
基本信息
- 批准号:7153553
- 负责人:
- 金额:$ 37.61万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2002
- 资助国家:美国
- 起止时间:2002-12-15 至 2008-11-30
- 项目状态:已结题
- 来源:
- 关键词:AccountingAntibodiesApoptosisApoptoticBiologyCell CycleCell Cycle ProgressionCell Cycle ProteinsCell ProliferationCell SurvivalCell physiologyCitiesConditionCyclin-Dependent KinasesCyclinsDeformityDegenerative DisorderDemyelinationsDisease ProgressionEnzymesFibroblast Growth FactorGenesGenomeGrowthGrowth FactorGrowth Factor ReceptorsHandHealthHumanImmunoblottingIn VitroInfectionInsulinInsulin-Like Growth Factor ILeadLeprosyLinkMetabolicMetabolic PathwayMicroarray AnalysisMitochondriaModelingMycobacterium lepraeNerveNerve Growth FactorsNerve RegenerationNervous System TraumaNeurogliaNeuronsNumbersPathway interactionsPatientsPeripheralPeripheral NervesPeripheral Nervous SystemPhenotypePreventionPropertyPseudogenesRegulationRespiratory ChainRespiratory physiologyReverse Transcriptase Polymerase Chain ReactionRoleSchwann CellsSecureSignal PathwaySignal TransductionSignaling MoleculeTimeTranscriptional ActivationUp-RegulationWeekcdc Genescell growthdaydisabilityglucose metabolismin vivoinhibitor/antagonistinsightneurotrophic factorneurotropicnovelnovel therapeuticspathogenreceptor
项目摘要
Leprosy remains an important global health problem, and represents a classical example of infectious neuro-
degenerative diseases of the peripheral nervous syetm (PNS). Mycobacterium leprae infection of Schwann
cell, the glial cell of the PNS, is the primary cause for the nerve damage in leprosy. We have recently shown
that the non-myelinating Schwann cell, but not the myelinated Schwann cell, preferentially harbors M. leprae,
and thus serves as the intracellular niche for persistent infection. Because M. leprae is an obligate intra-
cellular pathogen with the longest doubling time and limited number of genes in its genome, the
establishment of productive infection within non-myelinated Schwann cells is the key for bacterial survival.
However, the mechanisms of M. leprae survival within Schwann cells are unknown. Targeting of M. leprae
survival strategies will provide the rational to develop new therapeutics to combat the neurological injury and
disease progression. To study these aspects, we used primary human Schwann cells (isolated and purified
from human peripheral nerves) as a model, since they phenotypically resemble non-myelinated Schwann
cells in vivo. Intracellular M. leprae in vitro maintain viability for several weeks without causing any apoptosis
or cytopathic effect to Schwann cells. Microarray analysis using Affimatrix human GeneChips with cRNA
prepared from primary human Schwann cells infected with viable M. leprae for 30 days, we showed that the
majority of differentially expressed Schwann cells genes are (i) enzymes that regulate metabolic and
respiratory functions, (ii) cell cycle regulators/inhibitors, (iii) growth/neurotropic factors, (iv) growth factor
receptors and (v) associated transcriptional and signaling molecules. Therefore, we propose that once
infected, M. leprae effectively use Schwann cell machinery in one hand to maintain the bacterial viability and
the other hand to secure the intracellular niche for long-term bacterial survival by regulating Schwann cell
growth. To study these, we will study the following: (1) M. leprae regulation of Schwann cell metabolic/
catabolic functions, (2) Regulation of human Schwann cell cycle by M. leprae, and (3) M. leprae-induced
growth/neurotropic factors and their effects on Schwann cell signaling, growth and functions. These studies
should provide novel insight into the persistent M. leprae infection in the PNS, nerve damage in leprosy
patients, and the basic biology of glial cells.
city, state)
麻风病仍然是一个重要的全球健康问题,是传染性神经系统疾病的典型例子。
周围神经系统退行性疾病(PNS)。许旺氏麻风分枝杆菌感染
细胞(PNS的胶质细胞)是麻风病神经损伤的主要原因。我们最近的研究表明
无髓鞘的雪旺氏细胞,而不是有髓鞘的雪旺氏细胞,优先窝藏M。麻风病,
因此作为持续感染的细胞内小生境。因为M.麻风病是一种
在其基因组中具有最长倍增时间和有限数量基因的细胞病原体,
在无髓鞘雪旺细胞内建立生产性感染是细菌存活的关键。
然而,M.麻风病人在雪旺氏细胞中存活率是未知的。M的目标。麻风
生存策略将为开发新的治疗方法以对抗神经损伤提供合理性,
疾病进展。为了研究这些方面,我们使用原代人雪旺细胞(分离和纯化的
来自人外周神经)作为模型,因为它们在表型上类似于无髓鞘的Schwann
体内细胞胞内M.麻风在体外维持存活数周而不引起任何细胞凋亡
或对雪旺细胞的致细胞病变作用。使用Affimatrix人类基因芯片与cRNA的微阵列分析
由感染活M.麻风病30天,我们发现,
大多数差异表达的雪旺细胞基因是(i)调节代谢的酶,
呼吸功能,(ii)细胞周期调节剂/抑制剂,(iii)生长/神经营养因子,(iv)生长因子
受体和(v)相关的转录和信号分子。因此,我们建议,一旦
感染M.麻风病人一方面有效地利用许旺细胞机制来维持细菌活力,
另一方面通过调节雪旺细胞来确保细菌长期存活的细胞内生态位
增长为了研究这些现象,我们将研究以下几个方面:(1)M.麻风对雪旺细胞代谢调节/
(2)M.(3)M.麻风诱发的
生长/神经营养因子及其对雪旺细胞信号传导、生长和功能的影响。这些研究
应该提供新的见解持久的M。PNS中的麻风感染,麻风的神经损害
病人和神经胶质细胞的基础生物学。
城市,州)
项目成果
期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ANURA RAMBUKKANA其他文献
ANURA RAMBUKKANA的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ANURA RAMBUKKANA', 18)}}的其他基金
Targeting M. Leprae survival strategies in the PNS
针对 PNS 中的麻风分枝杆菌生存策略
- 批准号:
6987893 - 财政年份:2002
- 资助金额:
$ 37.61万 - 项目类别:
Targeting M. Leprae survival strategies in the PNS
针对 PNS 中的麻风分枝杆菌生存策略
- 批准号:
6822579 - 财政年份:2002
- 资助金额:
$ 37.61万 - 项目类别:
Targeting M. Leprae survival strategies in the PNS
针对 PNS 中的麻风分枝杆菌生存策略
- 批准号:
6562305 - 财政年份:2002
- 资助金额:
$ 37.61万 - 项目类别:
Targeting M. Leprae survival strategies in the PNS
针对 PNS 中的麻风分枝杆菌生存策略
- 批准号:
6688330 - 财政年份:2002
- 资助金额:
$ 37.61万 - 项目类别:
M. LEPRAE-INDUCED CONTACT-DEPENDENT DEMYELINATION
麻风杆菌引起的接触依赖性脱髓鞘
- 批准号:
6874035 - 财政年份:1999
- 资助金额:
$ 37.61万 - 项目类别:
M. LEPRAE-INDUCED CONTACT-DEPENDENT DEMYELINATION
麻风杆菌引起的接触依赖性脱髓鞘
- 批准号:
7016349 - 财政年份:1999
- 资助金额:
$ 37.61万 - 项目类别:
M. LEPRAE-INDUCED CONTACT-DEPENDENT DEMYELINATION
麻风杆菌引起的接触依赖性脱髓鞘
- 批准号:
7192492 - 财政年份:1999
- 资助金额:
$ 37.61万 - 项目类别:
相似海外基金
University of Aberdeen and Vertebrate Antibodies Limited KTP 23_24 R1
阿伯丁大学和脊椎动物抗体有限公司 KTP 23_24 R1
- 批准号:
10073243 - 财政年份:2024
- 资助金额:
$ 37.61万 - 项目类别:
Knowledge Transfer Partnership
Role of Natural Antibodies and B1 cells in Fibroproliferative Lung Disease
天然抗体和 B1 细胞在纤维增生性肺病中的作用
- 批准号:
10752129 - 财政年份:2024
- 资助金额:
$ 37.61万 - 项目类别:
CAREER: Next-generation protease inhibitor discovery with chemically diversified antibodies
职业:利用化学多样化的抗体发现下一代蛋白酶抑制剂
- 批准号:
2339201 - 财政年份:2024
- 资助金额:
$ 37.61万 - 项目类别:
Continuing Grant
Isolation and characterisation of monoclonal antibodies for the treatment or prevention of antibiotic resistant Acinetobacter baumannii infections
用于治疗或预防抗生素耐药鲍曼不动杆菌感染的单克隆抗体的分离和表征
- 批准号:
MR/Y008693/1 - 财政年份:2024
- 资助金额:
$ 37.61万 - 项目类别:
Research Grant
Discovery of novel nodal antibodies in the central nervous system demyelinating diseases and elucidation of the mechanisms through an optic nerve demyelination model
发现中枢神经系统脱髓鞘疾病中的新型节点抗体并通过视神经脱髓鞘模型阐明其机制
- 批准号:
23K14783 - 财政年份:2023
- 资助金额:
$ 37.61万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Elucidation of the mechanisms controlling the physicochemical properties and functions of supercharged antibodies and development of their applications
阐明控制超电荷抗体的理化性质和功能的机制及其应用开发
- 批准号:
23KJ0394 - 财政年份:2023
- 资助金额:
$ 37.61万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Developing first-in-class aggregation-specific antibodies for a severe genetic neurological disease
开发针对严重遗传神经系统疾病的一流聚集特异性抗体
- 批准号:
10076445 - 财政年份:2023
- 资助金额:
$ 37.61万 - 项目类别:
Grant for R&D
PLA2G2D Antibodies for Cancer Immunotherapy
用于癌症免疫治疗的 PLA2G2D 抗体
- 批准号:
10699504 - 财政年份:2023
- 资助金额:
$ 37.61万 - 项目类别:
Genetic adjuvants to elicit neutralizing antibodies against HIV
基因佐剂可引发抗艾滋病毒中和抗体
- 批准号:
10491642 - 财政年份:2023
- 资助金额:
$ 37.61万 - 项目类别:
Novel Immunogens to Elicit Broadly Cross-reactive Antibodies That Target the Hemagglutinin Head Trimer Interface
新型免疫原可引发针对血凝素头三聚体界面的广泛交叉反应抗体
- 批准号:
10782567 - 财政年份:2023
- 资助金额:
$ 37.61万 - 项目类别:














{{item.name}}会员




